BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34333850)

  • 1. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
    Liu J; Li LF
    J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
    Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
    Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
    Hampel A; Kinaciyan T
    Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
    [No Abstract]   [Full Text] [Related]  

  • 5. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with Infliximab: a case-based review.
    Keshavamurthy C; Fibeger E; Virata A; Bansal P
    ARP Rheumatol; 2022; 1(4):322-327. PubMed ID: 36617314
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
    Cohen PR
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
    Şikar Aktürk A; Bayramgürler D; Salman S; Yıldız KD; Odyakmaz Demirsoy E
    Cutan Ocul Toxicol; 2014 Dec; 33(4):337-8. PubMed ID: 24938451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?
    Häusermann P; Harr T; Bircher AJ
    Contact Dermatitis; 2004; 51(5-6):297-310. PubMed ID: 15606657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SDRIFE (baboon syndrome) due to paracetamol: case report.
    Lugović-Mihić L; Duvančić T; Vučić M; Situm M; Kolić M; Mihić J
    Acta Dermatovenerol Croat; 2013; 21(2):113-7. PubMed ID: 24001419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
    Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
    Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baboon syndrome and toxic erythema of chemotherapy: Fold (intertriginous) dermatoses.
    Wolf R; Tüzün Y
    Clin Dermatol; 2015; 33(4):462-5. PubMed ID: 26051062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
    Allain-Veyrac G; Lebreton A; Collonnier C; Jolliet P
    Am J Clin Dermatol; 2011 Jun; 12(3):210-3. PubMed ID: 21469764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
    Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
    J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral mucosal involvement and petechial lesions: a SDRIFE case with unusual findings.
    Karadag AS; Ozlu E; Akdeniz N; Uzuncakmak TK; Turkoglu Z; Ozkanli S; Zemheri E
    Cutan Ocul Toxicol; 2016; 35(2):157-9. PubMed ID: 26339719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
    Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
    J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635
    [No Abstract]   [Full Text] [Related]  

  • 17. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
    Kumar S; Bhale G; Brar BK
    Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
    [No Abstract]   [Full Text] [Related]  

  • 18. Symmetrical Drug-related Intertriginous and Flexural Exanthema (Baboon Syndrome).
    Lima Miranda O; Martins J; Almeida A; Formigo M; Pereira O; Rocha M; Cotter J
    Eur J Case Rep Intern Med; 2021; 8(12):003029. PubMed ID: 35059336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) induced by amoxicillin-clavulanate.
    Dogru M; Ozmen S; Ginis T; Duman H; Bostanci I
    Pediatr Dermatol; 2012; 29(6):770-1. PubMed ID: 22044408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with infliximab.
    Bulur I; Keseroglu HO; Saracoglu ZN; Gönül M
    J Dermatol Case Rep; 2015 Mar; 9(1):12-4. PubMed ID: 25932057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.